Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
13
×
Tags
boston blog main
boston top stories
13
×
life sciences
national blog main
san francisco blog main
biotech
san francisco top stories
national top stories
new york blog main
new york top stories
clinical trials
eli lilly
wisconsin blog main
wisconsin top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
deals
fda
cancer immunotherapy
startups
boehringer ingelheim
investing
johnson & johnson
medical device
medicare
merck
What
companies
13
×
new
bio
drug
life
roundup
ipo
science
week
latest
medicines
raised
therapeutics
therapies
ago
approval
big
biotech
biotechs
black
cancer
deal
diamond
disease
drugs
fda
hasn’t
leading
momentum
nash
neuro
news
pharmaceutical
price
research
rna
sciences
street
wall
year
Language
unset
Current search:
" boston top stories "
×
photo
×
companies
×
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines